Using the Internet-based upload blood glucose monitoring and therapy management system in patients with type 1 diabetes

The aim of this study is to assess the impact of the internet-based upload blood glucose monitoring and therapy management system (Carelink ® ) in patients with type 1 diabetes. Diabetic patients treated with pump infusion for ≥3 months were prospectively randomized to use the CareLink ® with (4 months) and without (4 months) diabetes-team initiated contact ( n = 36, intervention group) or to continue standard care for 4 months and then transfer to the CareLink ® without diabetes-team initiated contact ( n = 34, control group). In the first 4 months, treatment was adjusted monthly by the same team in both groups. Main outcome measures were HbA1c level and scores on the Diabetes Treatment Satisfaction and Diabetes Quality of Life Questionnaires. Patients who submitted